Reducing the burden on care settings and tackling elimination-related issues such as children’s toilet training: DFree Inc., which offers the elimination prediction device “DFree,” begins fundraising through new stock acquisition rights on FUNDINNO
Summary
DFree has started raising capital through FUNDINNO using new share warrants. The company plans to use the funds to expand production, strengthen deployment support, and improve service for care facilities, hospitals, and home users. It says demand has increased after a 2026 medical reimbursement change, but its supply and onboarding capacity have not kept up. DFree also highlights prior funding, clinical adoption, and product updates as it pushes toward broader domestic and international expansion.
Funding
Amount
None
Total raised
Date
July 29, 2026
Announcement date
Investors
Fundinno
Lead investors
Company
dfree.co.jp
Funded company
Classifications
industries
HealthTech
applications
No applications detected
AskAI Classifications
Labels
Healthcare Software
SaaS
Medical Device Software
Linked Companies
DFree株式会社 (DFree)
$1M to $5M